We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+5.62%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$143M
AUM Growth
-$9.08M
(-6%)
Cap. Flow
-$8.5M
Cap. Flow
% of AUM
-5.96%
Top 10 Holdings %
Top 10 Hldgs %
33.62%
Holding
128
New
4
Increased
25
Reduced
59
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rockwell Medical
RMTI
|
+$2.34M |
| 2 |
Veritone
VERI
|
+$939K |
| 3 |
QuickLogic
QUIK
|
+$939K |
| 4 |
DarioHealth
DRIO
|
+$540K |
| 5 |
TONX
TON Strategy Co
TONX
|
+$487K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBE
Cyberoptics Corp
CYBE
|
+$1.23M |
| 2 |
AngioDynamics
ANGO
|
+$1.05M |
| 3 |
Vericel Corp
VCEL
|
+$992K |
| 4 |
NVTA
Invitae Corporation
NVTA
|
+$939K |
| 5 |
QTNA
Quantenna Communications, Inc. Common Stock
QTNA
|
+$754K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.25% |
| 2 | Technology | 16.63% |
| 3 | Industrials | 6.45% |
| 4 | Communication Services | 5.82% |
| 5 | Consumer Staples | 2.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AT&T
T
$164B
| $1.73M | 1.21% |
68,467
+497
| +0.7% | +$11.9K |
|
27
LeMaitre Vascular
LMAT
$2.37B
| $1.71M | 1.2% |
61,130
+230
| +0.4% | +$6.39K |
|
28
Apyx Medical
APYX
$161M
| $1.71M | 1.2% |
254,040
+8,500
| +3% | +$46.2K |
|
29
Aflac
AFL
$65.5B
| $1.68M | 1.18% |
30,700
-150
| -0.5% | -$7.73K |
|
|
CEMI
30
DELISTED
Chembio diagnostics, Inc.
CEMI
| $1.48M | 1.04% |
243,300
-29,350
| -11% | -$198K |
|
|
IDXG
31
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $1.4M | 0.98% |
192,725
+500
| +0.3% | +$3.66K |
|
32
Target
TGT
$66.3B
| $1.35M | 0.95% |
15,640
-60
| -0.4% | -$4.85K |
|
33
Boston Scientific
BSX
$68.4B
| $1.28M | 0.9% |
29,850
| – | – |
|
34
Airgain
AIRG
$71.4M
| $1.24M | 0.87% |
87,800
-6,000
| -6% | -$86.7K |
|
|
ATRS
35
DELISTED
Antares Pharma, Inc.
ATRS
| $1.23M | 0.86% |
375,000
-66,000
| -15% | -$191K |
|
36
Champions Oncology
CSBR
$75.9M
| $1.12M | 0.78% |
142,550
-32,150
| -18% | -$282K |
|
|
CGRN
37
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $1.08M | 0.76% |
137,190
-300
| -0.2% | -$2.56K |
|
38
LifeVantage
LFVN
$80M
| $1.06M | 0.74% |
81,925
| – | – |
|
39
The Joint Corp
JYNT
$120M
| $1.04M | 0.73% |
57,300
-5,300
| -8% | -$90.2K |
|
|
VG
40
DELISTED
Vonage Holdings Corporation
VG
| $1.03M | 0.72% |
90,575
+3,850
| +4% | +$41.7K |
|
|
FPAY
41
DELISTED
FlexShopper
FPAY
| $998K | 0.7% |
907,600
+141,600
| +18% | +$129K |
|
42
Ciena
CIEN
$46.8B
| $997K | 0.7% |
24,250
-3,500
| -13% | -$135K |
|
|
HTGM
43
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $984K | 0.69% |
3,292
-152
| -4% | -$63.4K |
|
44
Verizon
VZ
$197B
| $963K | 0.67% |
16,850
-50
| -0.3% | -$2.88K |
|
45
Microvision
MVIS
$84.3M
| $907K | 0.64% |
1,126,500
| – | – |
|
|
TTSH
46
DELISTED
Tile Shop Holdings
TTSH
| $898K | 0.63% |
224,600
-39,000
| -15% | -$185K |
|
47
BioLife Solutions
BLFS
$1.54B
| $894K | 0.63% |
52,750
-8,000
| -13% | -$139K |
|
|
PDCO
48
DELISTED
Patterson Companies, Inc.
PDCO
| $870K | 0.61% |
37,975
+1,200
| +3% | +$26.7K |
|
49
Bristol-Myers Squibb
BMY
$129B
| $856K | 0.6% |
18,875
+6,000
| +47% | +$279K |
|
|
STRM
50
DELISTED
Streamline Health Solutions
STRM
| $842K | 0.59% |
37,169
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Perkins Capital Management held 128 positions worth $143M, down 6% from $152M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management withdrew a net $8.5M in Q2 2019, closing 17 positions and reducing 59 holdings. Its most notable exit was Cyberoptics Corp, an estimated $1.23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 60% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in QuickLogic worth $748K.
- Perkins Capital Management's largest Q2 2019 buy was QuickLogic: 92,857 shares worth $748K.
- Perkins Capital Management added most to Rockwell Medical in Q2 2019, an estimated $2.34M increase.
- Perkins Capital Management's biggest Q2 2019 reduction was Vericel Corp, cutting an estimated $992K.
- Perkins Capital Management fully exited Cyberoptics Corp in Q2 2019, selling an estimated $1.23M.
- Perkins Capital Management's ten largest holdings make up 34% of its $143M portfolio in Q2 2019.
- Perkins Capital Management opened 4 new positions and closed 17 in Q2 2019.
- Perkins Capital Management's portfolio value fell 6% quarter-over-quarter to $143M.
Based on Perkins Capital Management's 13F filing for Q2 2019, filed 9 Aug 2019.